September 25, 2020 2:38 pm
AstraZeneca has secured the European Union's backing in a confidential agreement which reflects the lower price sought by the British drugmaker, the official said.
September 23, 2020 11:56 am
The vaccine trial had been halted globally after a participant reported an adverse event. Following inquiry the trial was restarted. The Oxford vaccine trial will cover 1,600 participants in India across 10-12 sites.
September 27, 2020 12:49 pm
Coronavirus vaccine: The most-talked-about vaccines are being developed by AstraZeneca in partnership with Oxford University; Pfizer and BioNTech; Johnson and Johnson; Sanofi along with GlaxoSmithKline; and Novavax.
September 22, 2020 7:42 am
Coronavirus (COVID-19) vaccine latest update, September 16: Multiple news reports said the NIH had launched its own investigation into the incident that led to the halting of AstraZeneca vaccine trials two weeks ago.
September 12, 2020 10:00 pm
The company said it will continue to work with health authorities “across the world” and “be guided” as to when other clinical trials can resume.
September 16, 2020 1:51 pm
Oxford-AstraZeneca Coronavirus Vaccine: Trials of Oxford-AstraZeneca’s Covid-19 vaccine have been paused, reportedly after severe adverse reaction in a participant in England. What happens to the India trials? Why do some see it as a blessing in disguise?
September 09, 2020 10:58 am
In a statement, AstraZeneca described its decision to halt trials as "routine action which has to happen whenever there is potentially unexplained illness in one of the trials".
July 21, 2020 12:42 am
The Oxford AstraZeneca ChAdOx1 nCoV-19 vaccine candidate is currently undergoing large (Phase III) human trials in the United Kingdom and Brazil.
May 27, 2014 1:41 am
Pfizer’s final offer was at a price that many analysts had previously suggested would bring AstraZeneca to the table for serious negotiations.
May 20, 2014 1:04 am
Shares in AstraZeneca tumbled 13 per cent to £42 by late morning as prospects of a takeover ebbed away.